The information you provide to the chat will be collected and recorded to improve your experience and for quality assurance. Please read our privacy policy to see how we are storing and protecting your data.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
Beyond development: Using continuous manufacturing to accelerate OSD commercialization
On-demand webinar
Continuous manufacturing is no longer just a technical ambition—it’s a strategic asset. When paired with Real-Time Release Testing (RTRT), it offers measurable advantages in speed, scalability, and quality, particularly for oral solid dose (OSD) therapies approaching commercialization.
In this webinar, Douglas B. Hausner, Ph.D., senior manager of continuous manufacturing at Thermo Fisher Scientific, shares firsthand insights from supporting the company’s first OSD product submission enabled by continuous manufacturing and RTRT—filed across major global markets including the US and EU.
Key takeaways:
- How continuous manufacturing and RTRT enabled a successful global regulatory submission
- How this approach can accelerate timelines, enhance product quality, and reduce scale-up complexity
- The strategic value of integrating RTRT and continuous processes early in development
- Lessons from Phase III through commercial launch to inform your own strategy